Bioequivalency study as a method for confirming identity in original medications and generics

Bioequivalency study as a method for confirming identity in original medications and generics

.

Saved in:

Bibliographic Details
Main Authors:	S. Yu. Martsevich, Ya. V. Sukhanov, V. G. Belolipetskaya, N. P. Kutishenko
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2005-04-01
Series:	Российский кардиологический журнал
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/2476
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

BIOEQUIVALENCE STUDY OF GENERIC MOLNUPIRAVIR IN HEALTHY VOLUNTEERS
by: V. B. Vasilyuk, et al.
Published: (2023-02-01)

Bioequivalence study of generic nirmatrelvir in healthy volunteers
by: R. A. Oseshnyuk, et al.
Published: (2023-05-01)

Pharmacokinetics and bioequivalence of the generic and original dabigatran etexilate after a single dose in healthy volunteers
by: V. B. Vasilyuk, et al.
Published: (2024-10-01)

Original drugs and generics: are there any differences from the clinician’s point of view?
by: S. Yu. Martsevich, et al.
Published: (2024-10-01)

A COMPARATIVE ANALYSIS OF BIOEQUIVALENCE, CLINICAL EFFICACY AND SAFETY OF GENERIC VERSUS ORIGINAL CYCLOSPORINE AFTER KIDNEY TRANSPLANTATION
by: E. S. Stolyarevich, et al.
Published: (2015-04-01)

COMPARISON OF ANTIPLATELET EFFECT AND SAFETY OF ORIGINAL DRUG «ASPIRIN CARDIO» AND GENERIC«ACECARDOL» IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 GRADE
by: N. A. Belolipetskiy, et al.
Published: (2016-01-01)

CLINICAL AND PHARMACOKINETIC EQUIVALENCE OF ORIGINAL AND GENERIC AMLODIPINE IN PATIENTS WITH MILD-TO-MODERATE ARTERIAL HYPERTENSION
by: N. A. Belolipetskiy, et al.
Published: (2015-12-01)

A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC SIMVASTATIN IN PATIENTS WITH HYPERLIPIDEMIA
by: V. P. Voronina, et al.
Published: (2016-01-01)

VALUE OF THERAPEUTIC EQUIVALENCE IN SUBSTITUTION OF ORIGINAL DRUG WITH GENERIC BY EXAMPLE OF FOSINIPRIL
by: N. P. Kutishenko, et al.
Published: (2016-01-01)

Planning and Evaluation of Bioequivalence Studies of Telmisartan Generic Drug Products
by: A. L. Khokhlov, et al.
Published: (2019-09-01)

ASSESSMENT OF THERAPEUTICAL EQUIVALENCY OF ORIGINAL AND GENERIC INDAPAMIDE IN HYPERTENSIVE PATIENTS BY RANDOMIZED CROSS-OVER STUDY
by: N. P. Kutishenko, et al.
Published: (2015-12-01)

THE KARDIOKANON STUDY: A WAY TO SETTLE THE SUBJECT OF CLINICAL EQUIVALENCE OF GENERIC AND ORIGINAL DRUGS
by: S. Yu. Martsevich, et al.
Published: (2015-12-01)

Bisoprolol medications in a comparative study on effectiveness and tolerability of original agent and its generic in patients with mild to moderate arterial hypertension
by: S. Yu. Martsevich, et al.
Published: (2007-12-01)

COMPARATIVE PHARMACOKINETICS AND EFFECT ON THE HEMODYNAMICS OF ORIGINAL AND GENERIC NEBIVOLOL IN HEALTHY VOLUNTEERS
by: E. I. Bambysheva, et al.
Published: (2016-05-01)

ECONOMIC REASONS FOR GENERIC CHOICE
by: N. P. Kutishenko, et al.
Published: (2016-01-01)

WHAT IS THERAPEUTIC EQUIVALENCE OF GENERIC DRUG AND HOW TO PROVE IT
by: N. P. Kutishenko, et al.
Published: (2016-01-01)

How can practitioners orient themselves in generics variety?
by: S. Yu. Martsevich, et al.
Published: (2005-02-01)

Therapeutic equivalence of two amlodipine preparations (original and generic) in patients with arterial hypertension. Results of a double-blind, randomized cross-over study
by: S. Yu. Martsevich, et al.
Published: (2004-08-01)

A comparative study of the efficacy and safety of the original and generic orlistat in obese patients in the PROFIL register
by: A. V. Zakharova, et al.
Published: (2016-03-01)

Pharmacoeconomic Analysis of Therapy with Generic Statin Drugs in Patients with High and Very High Cardiovascular Risk (According to the Study PRIORITY)
by: S. Yu. Martsevich, et al.
Published: (2020-11-01)

GENERICS STATINS: ARE ALL SO EASY WITH EVIDENCE OF CLINICAL EQUIVALENCE?
by: S. Yu. Martsevich, et al.
Published: (2015-10-01)

Quality of reporting of bioequivalence trials comparing generic to brand name drugs: a methodological systematic review.
by: Amélie van der Meersch, et al.
Published: (2011-01-01)

COMPARISON OF NEW GENERIC AND ORIGINAL RAMIPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION AND HIGH CARDIOVASCULAR RISK
by: S. Yu. Martsevich, et al.
Published: (2016-01-01)

COMPARATIVE EVALUATION OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC BISOPROLOL IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 GRADE
by: S. N. Tolpygina, et al.
Published: (2015-12-01)

The Role of ICS/LABA Fixed-Dose Combinations in the Treatment of Asthma and COPD: Bioequivalence of a Generic Fluticasone Propionate-Salmeterol Device
by: Donald P. Tashkin, et al.
Published: (2021-01-01)

ESTIMATION OF CLINICAL AND PHARMACOKINETIC EQUIVALENCE OF ORIGINAL AND GENERIC CARVEDILOLS IN PATIENTS WITH HYPERTENSION OF 1-2 GRADES
by: E. I. Bambysheva, et al.
Published: (2016-01-01)

Bioequivalence study drug containing memantine
by: A. A. Karlitskaya, et al.
Published: (2013-09-01)

ACHIEVEMENT OF TARGET BLOOD PRESSURE LEVEL IN HYPERTENSIVE PATIENTS WITH AMLODIDINE: ORIGINAL DRUG VERSUS GENERIC
by: S. Yu. Martsevich, et al.
Published: (2016-01-01)

COMPARISON OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC DRUGS OF SIMVASTATIN IN PATIENTS WITH HYPERLIPIDAEMIA AND HIGH RISK OF ISCHEMIC HEART DISEASE COMPLICATIONS
by: S. N. Tolpygina, et al.
Published: (2016-01-01)

PLANNING AND EVALUATION OF BIOEQUIVALENCE STUDIES OF ATAZANAVIR PRODUCTS
by: N. E. Uvarova, et al.
Published: (2018-12-01)

PROBLEM OF GENERIC REPLACEMENT: ADVANTAGES AND DISADVANTAGES
by: S. N. Tolpygina, et al.
Published: (2016-01-01)

EFFICIENCY AND SAFETY ASSESSMENT OF GENERIC ATORVASTATINE IN PATIENTS WITH HYPERLIPIDEMIA
by: J. E. Semyonova, et al.
Published: (2015-12-01)

A sex-sensitive LC-MS/MS method with isotopic internal standard for prazosin bioequivalence: bridging precision medicine and generic drug policy in China
by: Hui Chen, et al.
Published: (2025-05-01)

Biowaiver as a Bioequivalence Study Option
by: E. A. Volkova, et al.
Published: (2024-02-01)

Comparative effectiveness of original and generic losartan in patients with arterial hypertension
by: S. V. Nedogoda, et al.
Published: (2007-12-01)

PHARMACOKINETIC RESEARCHES AND PRACTICAL MEDICINE
by: V. G. Belolipetskaya, et al.
Published: (2015-12-01)

From In Vivo Predictive Dissolution to Virtual Bioequivalence: A GastroPlus<sup>®</sup>-Driven Framework for Generic Candesartan Cilexetil Tablets
by: Hao Ruan, et al.
Published: (2025-04-01)

COMPARISON OF ANTIPLATELET EFFICACY OF ORIGINAL AND GENERIC ENTEROSOLUBLE ACETYLSALICYLIC ACID IN PATIENTS WITH HIGH CARDIOVASCULAR RISK. SIMPLE BLIND CROSSED RANDOMIZED CONTROLLED STUDY (IKAR)
by: S. Yu. Martsevich, et al.
Published: (2016-01-01)

STATIN GENERICS: EFFICACY AND SAFETY RATIO
by: V. P. Voronina, et al.
Published: (2016-01-01)

Pharmacokinetics and Safety with Bioequivalence of Isosorbide Mononitrate Sustained-Release Tablets in Chinese Healthy Volunteers: Bioequivalence Study
by: Wu B, et al.
Published: (2025-07-01)